U S PHYSICAL THERAPY INC /NV (USPH)

78.63USD -0.59% (-0.47)

Over 1M: +0.0%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

76 78 80 82
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Revenue: 197.1M Q3 '25 — Cost of Revenue: 160.3M Q3 '25 — Free Cash Flow: 15.6M Q4 '25 — Revenue: 202.7M Q4 '25 — Cost of Revenue: 162.6M Q4 '25 — Free Cash Flow: 21M Q1 '26 — Revenue: 198.3M Q1 '26 — Cost of Revenue: 165.5M Q1 '26 — Free Cash Flow: -1.6M Q2 '26 — Revenue: 214.1M Q2 '26 — Cost of Revenue: 172.1M Q2 '26 — Free Cash Flow: 29M 0 50M 100M 150M 200M 250M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Cost of Revenue Free Cash Flow

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

4.0
OE margin 6.7%
ROIC 9.4%
Accruals -4.1%
FCF margin 7.9%
OCF margin 10.2%
ROA 2.6%
ROCE 6.7%
ROE 7.2%
OCF / EBIT 1.1×
Gross margin 18.7%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

7.4
EV/EBIT 18.0×
EV/OE 25.4×
Div. yield 1.8%
EV/Sales 1.7×
FCF yield 5.4%
P/B 2.6×
EV/GP 9.1×
P/E 36.7×
P/C 47.6×
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.6
RPO / sales 0.00093×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.7
ND/EBITDA -0.14
Net debt / Eq 0.43×
Debt / Eq 0.49×
Debt payback 3.0 yr
F-score 6.0 pts
Quick ratio 1.3×
Cash / Debt 0.11×
Payout 64.8%
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.1
Sales CAGR 4Y +12.1%
Sales/sh Y/Y +10.5%
Shares change +0.74%
Div. growth +3.1%
EBIT CAGR +8.9%
Sales Q/Q +8.5%
EBIT Y/Y -0.72%
EPS Y/Y -16.2%
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.